Diabetes mellitus and decompensated cirrhosis: Risk of hepatic encephalopathy in different age groups

Journal of Diabetes

Volumn 5, Issue 4, 2013, Pages 449-455

  Butt, Zeeshan ^a,b   Jadoon, Nauman A ^b,c   Salaria, Osman N ^a   Mushtaq, Kamran ^b,c   Riaz, Irbaz B ^c   Shahzad, Ahmed ^c   Hashmi, Ali M ^a   Sarwar, Shahid ^a  

^a KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

^b Center for Biomedical Research   (Pakistan)

^c NISHTAR MEDICAL COLLEGE   (Pakistan)

Author keywords

Diabetes complications; Hepatic encephalopathy; Liver cirrhosis; Old age

Indexed keywords

CREATININE;

ADULT; ARTICLE; ASCITES; CHILD PUGH SCORE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DIABETES MELLITUS; DISEASE SEVERITY; END STAGE LIVER DISEASE; ESOPHAGUS VARICES; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RANK SUM TEST; SPLENOMEGALY; STRUCTURED QUESTIONNAIRE; STUDENT T TEST; THROMBOCYTE COUNT;

DIABETES COMPLICATIONS; HEPATIC ENCEPHALOPATHY; LIVER CIRRHOSIS; OLD AGE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84887025206     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12067     Document Type: Article

References (23)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy: Definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002; 35: 716-721.
2. Li YY, Nie YQ, Sha WH etal. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol. 2004; 10: 2397-2401.
3. Poh Z, Chang PE. A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol. 2012; 2012: 480309.
4. Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: Key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol. 1987; 6: 1-12.
5. Ampuero J, Ranchal I, Del Mar Díaz-Herrero M, Del Campo JA, Bautista JD, Romero-Gómez M. Role of diabetes mellitus on hepatic encephalopathy. Metab Brain Dis. 2013; 28: 277-279.
6. Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol. 2012; 18: 6693-6700.
7. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World J Gastroenterol. 2009; 15: 280-288.
8. Madsen JL, Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing. 2004; 33: 154-159.
9. Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol. 2006; 101: 1490-1496.
10. Kalaitzakis E, Olsson R, Henfridsson P etal. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int. 2007; 27: 1194-1201.
11. Ling Q, Xu X, Wei Q etal. Impact of preexisting diabetes mellitus on outcome after liver transplantation in patients with hepatitis B virus-related liver disease. Dig Dis Sci. 2011; 56: 889-893.
12. Kalaitzakis E, Josefsson A, Björnsson E. Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: A cross-sectional study. BMC Gastroenterol. 2008; 8: 46.
13. Kamath PS, Wiesner RH, Malinchoc M etal. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33: 464-470.
14. National Cancer Institute. Common terminology criteria for adverse events v.4.0 (CTCAE). Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm (accessed 14 June 2010).
15. Abrahamsson H. Gastrointestinal motility disorders in patients with diabetes mellitus. J Intern Med. 1995; 237: 403-409.
16. Kawaguchi T, Taniguchi E, Itou M, Sakata M, Sumie S, Sata M. Insulin resistance and chronic liver disease. World J Hepatol. 2011; 3: 99-107.
17. Jadoon NA, Shahzad MA, Yaqoob R, Hussain M, Ali N. Seroprevalence of hepatitis C in type 2 diabetes: Evidence for a positive association. Virol J. 2010; 7: 304.
18. Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007; 30: 734-743.
19. Veldt BJ, Chen W, Heathcote EJ etal. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 2008; 47: 1856-1862.
20. Baffy G. Hepatocellular carcinoma in type 2 diabetes: More than meets the eye [Editorial]. Am J Gastroenterol. 2012; 107: 53-55.
21. Kwon SY, Kim SS, Kwon OS etal. Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus. Diabet Med. 2005; 22: 1530-1535.
22. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology. 1994; 20: 119-125.
23. Eslam M, Aparcero R, Kawaguchi T etal. Meta-analysis: Insulin resistance and sustained virological response in hepatitis C. Aliment Pharmacol Ther. 2011; 34: 297-305.